Free Trial

Corteva (CTVA) Stock Forecast & Price Target

Corteva logo
$76.53 -0.59 (-0.77%)
Closing price 07/7/2025 03:58 PM Eastern
Extended Trading
$76.59 +0.06 (+0.08%)
As of 07/7/2025 06:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Corteva - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
3
Buy
11

Based on 14 Wall Street analysts who have issued ratings for Corteva in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 14 analysts, 3 have given a hold rating, and 11 have given a buy rating for CTVA.

Consensus Price Target

$72.50
-5.27% Downside
According to the 14 analysts' twelve-month price targets for Corteva, the average price target is $72.50. The highest price target for CTVA is $82.00, while the lowest price target for CTVA is $55.00. The average price target represents a forecasted downside of -5.27% from the current price of $76.53.
Get the Latest News and Ratings for CTVA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Corteva and its competitors.

Sign Up

CTVA Analyst Ratings Over Time

TypeCurrent Forecast
7/8/24 to 7/8/25
1 Month Ago
6/8/24 to 6/8/25
3 Months Ago
4/9/24 to 4/9/25
1 Year Ago
7/9/23 to 7/8/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
11 Buy rating(s)
13 Buy rating(s)
14 Buy rating(s)
15 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
6 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$72.50$70.50$68.06$63.00
Forecasted Upside-5.27% Downside-1.67% Downside15.95% Upside21.81% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

CTVA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CTVA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Corteva Stock vs. The Competition

TypeCortevaConsumer Staples CompaniesS&P 500
Consensus Rating Score
2.79
2.54
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside-5.27% Downside59.96% Upside10.81% Upside
News Sentiment Rating
Positive News

See Recent CTVA News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/7/2025Barclays
3 of 5 stars
Benjamin Theurer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetEqual Weight ➝ Equal Weight$70.00 ➝ $75.00-2.09%
6/23/2025Wells Fargo & Company
3 of 5 stars
Richard Garchitorena
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$79.00 ➝ $82.00+9.63%
6/6/2025Jefferies Financial Group
2 of 5 stars
Laurence Alexander
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/9/2025Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Kristen Owen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$72.00 ➝ $75.00+11.05%
5/9/2025Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Patrick Cunningham
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$75.00 ➝ $78.00+15.86%
5/9/2025Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Vincent Andrews
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$65.00 ➝ $71.00+5.47%
5/9/2025KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Aleksey Yefremov
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$71.00 ➝ $72.00+7.49%
5/8/2025UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Joshua Spector
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$74.00 ➝ $76.00+14.17%
3/31/2025Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Bill Selesky
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$69.00 ➝ $69.00+12.96%
3/13/2025The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Duffy Fischer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$71.00+20.19%
2/11/2025Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Steve Byrne
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$69.00 ➝ $73.00+17.36%
2/10/2025BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
L. Favre
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
2/7/2025Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Arun Viswanathan
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$72.00 ➝ $73.00+17.09%
8/2/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$57.00 ➝ $55.00+6.63%
6/18/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$61.00 ➝ $60.00+15.27%
6/12/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$65.00 ➝ $65.00+25.90%
6/7/2024OTR Global
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMixed ➝ Negative
5/3/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$60.00 ➝ $65.00+13.72%
5/3/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$64.00 ➝ $67.00+17.13%
3/1/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$67.00+25.30%
2/12/2024Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$57.00 ➝ $65.00+21.27%
11/27/2023Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$63.00 ➝ $52.00+11.42%
11/22/2023Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$82.00 ➝ $63.00+36.45%
8/4/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$74.00+31.95%
7/25/2023Redburn Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 04:41 AM ET.


Should I Buy Corteva Stock? CTVA Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, July 4, 2025. Please send any questions or comments about these Corteva pros and cons to contact@marketbeat.com.

Corteva
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Corteva, Inc.:

  • The current stock price is around $77, reflecting a strong performance in the market.
  • Corteva, Inc. has received multiple "buy" ratings from analysts, indicating positive sentiment and potential for growth.
  • The company reported earnings per share of $1.13, exceeding analysts' expectations, which suggests strong financial health.
  • With a market capitalization of approximately $52.69 billion, Corteva, Inc. is positioned as a significant player in the agriculture sector.
  • The firm has a low debt-to-equity ratio, indicating a strong balance sheet and lower financial risk for investors.

Corteva
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Corteva, Inc. for these reasons:

  • The company's revenue has shown a slight decline year-over-year, which may raise concerns about future growth.
  • Despite positive earnings, the price-to-earnings ratio is relatively high, suggesting that the stock may be overvalued compared to its earnings.
  • Market volatility could impact stock performance, as indicated by the company's beta of 0.76, which reflects lower volatility compared to the market.
  • Analysts have set a moderate average target price, which may limit upside potential for investors looking for significant gains.
  • Dividend yield is relatively low at 0.88%, which may not attract income-focused investors.

CTVA Forecast - Frequently Asked Questions

According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Corteva is $72.50, with a high forecast of $82.00 and a low forecast of $55.00.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Corteva in the last year. There are currently 3 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CTVA shares.

According to analysts, Corteva's stock has a predicted downside of -5.27% based on their 12-month stock forecasts.

Corteva has been rated by research analysts at Barclays, Citigroup, Jefferies Financial Group, KeyCorp, Morgan Stanley, Oppenheimer, UBS Group, and Wells Fargo & Company in the past 90 days.

Analysts like Corteva more than other "consumer staples" companies. The consensus rating score for Corteva is 2.79 while the average consensus rating score for "consumer staples" companies is 2.54. Learn more on how CTVA compares to other companies.


This page (NYSE:CTVA) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners